RFX1

gene product
EF-C
This gene encodes a member of the regulatory factor X (RFX) family of transcription factors, which are characterized by a winged-helix DNA-binding domain. The encoded transcription factor contains an N-terminal activation domain and a C-terminal repression domain, and may activate or repress target gene expression depending on cellular context. This transcription factor has been shown to regulate a wide variety of genes involved in immunity and cancer, including the MHC class II genes and genes that may be involved in cancer progression. This gene exhibits altered expression in glioblastoma and the autoimmune disease systemic lupus erythematosis (SLE). [provided by RefSeq, Jul 2016]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
178 antibodies from 25 providers.

Antibody properties

General

Applications

or Cancel
Antibody
Novus Biologicals
5 antibodies
antibodies-online
57 antibodies
LifeSpan BioSciences, Inc.
37 antibodies
GeneTex
2 antibodies
Boster Biological Technology
1 antibody
Abiocode, Inc.
3 antibodies
Biorbyt
14 antibodies
Cusabio Biotech Co., Ltd
4 antibodies
Bethyl Laboratories
2 antibodies
Invitrogen Antibodies
6 antibodies
OriGene
6 antibodies
Abgent
2 antibodies
Atlas Antibodies
1 antibody
ProSci
2 antibodies
Proteintech Group
1 antibody
Aviva Systems Biology
5 antibodies
Acris Antibodies GmbH
1 antibody
MyBioSource
2 antibodies
Abbexa
5 antibodies
United States Biological
13 antibodies
Creative Diagnostics
1 antibody
Leading Biology
1 antibody
Creative Biolabs
4 antibodies
MilliporeSigma / Merck KGaA
2 antibodies
Abnova Corporation
1 antibody